The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving and tissue homeostatic actions. Maresin 1 (MaR1; 7 R ,14 S ‐dihydroxy‐docosa‐4 Z ,8 E ,10 E ,12 Z ,16 Z ,19 Z ‐hexaenoic acid) is the first identified maresin. Here, we investigate formation, stereochemistry, and precursor role of 13,14‐epoxy‐docosahexaenoic acid, an intermediate in MaR1 biosynthesis. The 14‐lipoxygenation of DHA by human macrophage 12‐lipoxygenase (hm12‐LOX) gave 14‐hydro(peroxy)‐docosahexaenoic acid (14‐HpDHA), as well as several dihydroxy‐docosahexaenoic acids, implicating an epoxide intermediate formation by this enzyme. Using a stereo‐controlled synthesis, enantiomerically pure 13 S ,14 S ‐epoxy‐docosa‐4 Z ,7 Z ,9 E ,11 E ,16 Z ,19 Z ‐hexaenoic acid (13 S ,14 S ‐epoxy‐DHA) was prepared, and its stereochemistry was confirmed by NMR spectroscopy. When this 13 S ,14 S ‐epoxide was incubated with human macrophages, it was converted to MaR1. The synthetic 13 S ,14 S ‐epoxide inhibited leukotriene B 4 (LTB 4 ) formation by human leukotriene A 4 hydrolase (LTA 4 H) ~40% ( P <0.05) to a similar extent as LTA4 (~50%, P <0.05) but was not converted to MaR1 by this enzyme. 1 3S ,14 S ‐epoxy‐DHA also reduced (~60%; P <0.05) arachidonic acid conversion by hm12‐LOX and promoted conversion of M1 macrophages to M2 phenotype, which produced more MaR1 from the epoxide than M1. Together, these findings establish the biosynthesis of the 13 S ,14 S ‐epoxide, its absolute stereochemistry, its precursor role in MaR1 biosynthesis, and its own intrinsic bioactivity. Given its actions and role in MaR1 biosynthesis, this epoxide is now termed 13,14‐epoxy‐maresin (13,14‐eMaR) and exhibits new mechanisms in resolution of inflammation in its ability to inhibit proinflammatory mediator production by LTA4 hydrolase and to block arachidonate conversion by human 12‐LOX rather than merely terminating phagocyte involvement.—Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., Serhan, C. N. The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H) and shifts macrophage phenotype. FASEB J. 27, 2573–2583 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 10×
“In the biosynthesis of MaR1, DHA undergoes 14S-lipoxygenation to give 14-HpDHA that is converted to 13S,14S-epoxy-DHA, a proposed intermediate that is then further transformed to MaR1 (8).”
BackgroundMethodInfluentialSelf-citationResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · cited 1×
“The ability to identify resolvins revealed their remarkable protective actions, including their ability to enhance immune vigilance (23) and to stimulate host immune responses, lowering antibiotic requirements during infection (24).”
BackgroundSelf-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Self-citationMacrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C., Xu, Z., Ji, R., Zhu, M., & Petasis, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-201442 · Cited by 595 · cited 7×
“We next determined the identity of these DHA-derived products by assessing their respective MS-MS spectra and matching with synthetic and/or authentic standards (11).”
BackgroundInfluentialSelf-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576 · cited 1×
“3 min that corresponded to the known nonenzymatic hydrolysis products of LTA4 (3, 4) with the major peak at TR 5.”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Self-citationFatty acids and inflammation: The cutting edge between food and pharma
Calder, P. C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.085 · Cited by 516 · cited 1×
“It is now well appreciated that -3 fatty acids exert a positive bearing on several important aspects of cardiovascular disease (30, 31).”
BackgroundMetabolic oxidation regulates embryonic stem cell differentiation
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., Trauger, S. A., Desponts, C., Ding, S., & Siuzdak, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.364 · Cited by 506
Cited by
Items 101–200 of 283
Macrophage Polarization, Metabolic Reprogramming, and Inflammatory Effects in Ischemic Heart Disease
Sun, X., Li, Y., Deng, Q., Hu, Y., Dong, J., Wang, W., Wang, Y., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.934040 · Cited by 51
“However, the resulting secretion of pro-inflammatory cytokines alters extracellular homeostasis and intracellular transcription, and this reciprocal network effect feeds back into the persistent M1 polarization until energy metabolic process reaches a dynamic balance with the regulation of cellular functions (14), suc…”
BackgroundSerhan, C. N., & Chiang, N. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106718 · Cited by 59
Self-citationHansen, T. V., Dalli, J., & Serhan, C. N. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.06.003 · Cited by 52
“Interestingly, these authors reproted that the 13S,14S-MaR epoxide inhibited the LTA4-hydrolase enzyme [55].”
Self-citationAllen, B. L., Montague-Cardoso, K., Simeoli, R., Colas, R. A., Oggero, S., Vilar, B., McNaughton, P. A., Dalli, J., Perretti, M., Sher, E., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001908 · Cited by 53
Self-citationMaresin 1 induces a novel pro‐resolving phenotype in human platelets
Lannan, K. L., Spinelli, S., Blumberg, N., & Phipps, R. P. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13620 · Cited by 55
Crouch, M. J., Kosaraju, R., Guesdon, W., Armstrong, M., Reisdorph, N. A., Jain, R., Fenton, J. I., & Shaikh, S. R. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi1017-405rr · Cited by 53
Molecular insights into lipoxygenases for biocatalytic synthesis of diverse lipid mediators
An, J.-U., Kim, S., & Oh, D. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101110 · Cited by 51
Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation
Peh, H. Y., & Chen, J. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108753 · Cited by 56
Pinel, A., Morio, B., & Capel, F. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0303-2 · Cited by 53
“It was also recently found that an epoxide intermediate molecule produced from DHA by the enzymatic action of 12 lipoxygenase can change the polarization of human macrophages to the alternate M2 profile [21].”
BackgroundRecchiuti, A., Codagnone, M., Pierdomenico, A. M., Rossi, C., Mari, V. C., Cianci, E., Simiele, F., Gatta, V., & Romano, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-248393 · Cited by 53
“Having established that orally administered RvD1 exerts potent anti-inflammatory and proresolution actions and since RvD1 regulates gene expression in M s (28, 29, 46), we examined whether it acted on epigenetic mechanisms that control the transcription of genes in M s, since they have crucial roles in regulating thei…”
BackgroundLee, C. H. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01299-y · Cited by 51
“These lipids mediators alleviate the SARSCoV-2 cytokine storm, while arachidonic acid, dihomogamma-linolenic acid, and gamma-linolenic acid inactivate enveloped viruses (Das 2020).”
BackgroundDihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance
Balas, L., & Durand, T. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.10.002 · Cited by 48
Maresin-1 resolution with RORα and LGR6
Im, D. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101034 · Cited by 48
Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Fiala, M., Kooij, G., Wagner, K., Hammock, B., & Pellegrini, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44
Dasilva, G., Muñoz, S., Lois, S., & Medina, I. (2019) · Molecules · doi:10.3390/molecules24122276 · Cited by 46
Wang, Y., Li, Y., Wang, J.-N., Zhao, Q.-X., Jin, J., Wen, S., Wang, S.-C., & Sun, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00831 · Cited by 49
“Increasing evidence has shown that the actions of MaR1 in anti-inflammatory and proinflammatory resolution are more promising than those already reported such as resolvins (Serhan et al., 2009, 2012; Dalli et al., 2013).”
BackgroundGPR37L1 identifies spinal cord astrocytes and protects neuropathic pain after nerve injury
Xu, J., Yan, Z., Bang, S., Velmeshev, D., & Ji, R. (2025) · Neuron · doi:10.1016/j.neuron.2025.01.012 · Cited by 50
Redox (phospho)lipidomics of signaling in inflammation and programmed cell death
Tyurina, Y. Y., Croix, C. M. S., Watkins, S. C., Watson, A. M., Epperly, M. W., Anthonymuthu, T. S., Kisin, E. R., Vlasova, I. I., Krysko, O., Krysko, D. V., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0119-004rr · Cited by 49
Anti-inflammatory signaling through G protein-coupled receptors
Ge, Y., Liao, Q., Xu, Y., Zhao, Q., Wu, B., & Ye, R. D. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00523-1 · Cited by 46
Aursnes, M., Tungen, J. E., Colas, R. A., Vlasakov, I., Dalli, J., Serhan, C. N., & Hansen, T. V. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00574 · Cited by 47
Self-citationFreedman, C. J., Tran, A., Tourdot, B. E., Kalyanaraman, C., Perry, S., Holinstat, M. A., Jacobson, M. P., & Holman, T. R. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00233 · Cited by 44
Wang, Q., Yan, S.-F., Yu, H., & Jin, S. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.229890 · Cited by 45
Phospholipase A2 in skin biology: new insights from gene-manipulated mice and lipidomics
Murakami, M., Yamamoto, K., & Taketomi, Y. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0089-2 · Cited by 47
Resolution of inflammation in oral diseases
Eltay, E. G., & Dyke, T. E. V. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108453 · Cited by 46
Fiala, M., Terrando, N., & Dalli, J. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150367 · Cited by 41
“This ability to switch macrophages from an inflammatory to a tissue protective/pro-resolving phenotype was also found with other pro-resolving mediators, including the maresin conjugates in tissue regeneration (MCTR1 and MCTR2) [59], maresin 1, as well as the maresin biosynthetic intermediate 13S, 14S-epoxy-MaR (13S,1…”
Self-citationFunction of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 45
Unified nexus of macrophages and maresins in cardiac reparative mechanisms
Jadapalli, J. K., & Halade, G. V. (2018) · The FASEB Journal · doi:10.1096/fj.201800254r · Cited by 42
“Recently a new bioactive MaR metabolome was identified as 13R,14S dihydroxy4Z,7Z,9E,11E,16Z,19Z-hexaenoic acid (Mar-2), which displays anti-inflammatory, proresolving, and antiatherosclerotic effects (Table 1) (76, 77).”
BackgroundLiu, W., Yang, Y.-H., Wang, Y.-C., Chang, W., & Wang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311012 · Cited by 45
Gao, J., Tang, C., Tai, L. W., Ouyang, Y., Li, N., Hu, Z., & Chen, X. (2018) · Journal of Pain Research · doi:10.2147/jpr.s160779 · Cited by 38
“It is synthesized in macrophages and derived from fatty acid docosahexaenoic acid (DHA), inducing the biosynthesis of protective mediators such as MaR1 (7R,14S-dihydroxy4Z,8E,10E,12Z,16Z,19Z-DHA).(11,12) Previous studies have shown that MaR1 protects the central nervous system from ischemic injuries by its pro-resolut…”
BackgroundRoles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches
Hao, W., Li, M., Cai, Q., Wu, S., Li, X., He, Q., & Hu, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.889792 · Cited by 47
The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies
Giardini, E., Moore, D., Sadlier, D. M., Godson, C., & Brennan, E. P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118615 · Cited by 43
“Here, macrophage-derived 12-LOX acts on DHA to form 14-hydroxydo-cosahexaenoic acid (14-HDHA), which in turn can be further metabolized to 13S, 14S-epoxy-maresin, finally forming maresin-1 (MaR1) or maresin 2 (MaR2) [98,99].”
Specialized pro-resolving mediators in renal fibrosis
Brennan, E. P., Cacace, A., & Godson, C. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.05.001 · Cited by 36
Chataigner, M., Martin, M., Lucas, C., Pallet, V., Layé, S., Mehaignerie, A., Bouvret, E., Dinel, A., & Joffre, C. (2021) · Nutrients · doi:10.3390/nu13030824 · Cited by 38
“Mar1 was first identified in macrophages and is involved in the resolution of inflammation [88,89].”
BackgroundStereoselective synthesis of maresin 1
Tungen, J. E., Aursnes, M., & Hansen, T. V. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.02.080 · Cited by 35
Atomic determinants of BK channel activation by polyunsaturated fatty acids
Tian, Y., Aursnes, M., Hansen, T. V., Tungen, J. E., Galpin, J. D., Leisle, L., Ahern, C. A., Xu, R., Heinemann, S. H., & Hoshi, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615562113 · Cited by 35
“Physiologically, DHA is converted to other signaling molecules such as maresin 1 (22), protectin D1 and DX (23), and 17-keto DHA (24) with multiple OH groups.”
BackgroundSun, Q., Wu, Y., Zhao, F., & Wang, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6711 · Cited by 35
“1A), known as maresin 1 (MaR 1) (11).”
Dwyer, G. K., & Turnquist, H. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611910 · Cited by 39
“org 10 those reflective of IL-4-activated macrophages, which, as discussed, are characterized by high levels of FA uptake and are the primary source of maresins (104).”
BackgroundRoles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
Yin, P., Wei, Y., Wang, X., Zhu, M., & Feng, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00617 · Cited by 35
“MaR1 has also been shown to stimulate the M1 to M2 phenotype transformation besides its pro-resolving bio functions and tissue restorative abilities (178).”
BackgroundSelf-citationUnexpected Role of MPO-Oxidized LDLs in Atherosclerosis: In between Inflammation and Its Resolution
Tangeten, C., Boudjeltia, K. Z., Delporte, C., Antwerpen, P. V., & Korpak, K. (2022) · Antioxidants · doi:10.3390/antiox11050874 · Cited by 39
Decreased Plasma Maresin 1 Concentration Is Associated with Diabetic Foot Ulcer
Tian, M., Huang, B., He, N., Sun, L., Du, G., Gong, X., Xu, Y., Zheng, Y., Zheng, H., & Qu, H. (2020) · Mediators of Inflammation · doi:10.1155/2020/4539035 · Cited by 33
“The latter is further transformed by 13 (14)-epoxidation, which is an important process of biosynthesis of 7R, 14 dihydroxydocosa-4Z, 8E, 10E, 12Z, 16Z, 19Z hexanoic acid, which are named as MaR1 [23, 24].”
BackgroundMaresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice
Laiglesia, L. M., Escoté, X., Sáinź, N., Félix‐Soriano, E., Santamaría, E., Collantes, M., Fernández‐Galilea, M., Colón-Mesa, I., Martínez‐Fernández, L., Quesada‐López, T., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101749 · Cited by 33
“MaR1 and its precursor promote the shift of macrophage phenotype toward an M2 profile [17].”
BackgroundSelf-citationGroup IID, IIE, IIF and III secreted phospholipase A2s
Murakami, M., Miki, Y., Sato, H., Murase, R., Taketomi, Y., & Yamamoto, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.014 · Cited by 33
Zúñiga‐Hernández, J., Sambra, V., Echeverría, F., Videla, L. A., & Valenzuela, R. (2022) · Food & Function · doi:10.1039/d1fo03551g · Cited by 34
Wang, F., Yang, G., Chen, T., Li, B., Zhang, W., Yin, L., Zhào, H., Tang, Y., Wang, X., & Huang, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109369 · Cited by 30
Pro-Resolving Ligands Orchestrate Phagocytosis
Decker, C., Sadhu, S., & Fredman, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660865 · Cited by 38
Sorokin, A. V., Arnardottir, H. H., Svirydava, M., Ng, Q., Baumer, Y., Berg, A., Pantoja, C. J., Florida, E. M., Teague, H., Yang, Z., et al. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109348 · Cited by 35
Orchestrating Role of Apoptosis Inhibitor of Macrophage in the Resolution of Acute Lung Injury
Kimura, H., Suzuki, M., Konno, S., Shindou, H., Shimizu, T., Nagase, T., Miyazaki, T., & Nishimura, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601798 · Cited by 31
Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents
Jouvene, C. C., Shay, A. E., Soens, M., Norris, P. C., Haeggström, J. Z., & Serhan, C. N. (2019) · The FASEB Journal · doi:10.1096/fj.201902003r · Cited by 30
“Along these lines, we found that eMaR inhibits LTB4 production by LTA4H (40), and this inhibitory actionwas also a property of ePD (Fig.”
BackgroundMethodSelf-citationQuenching the fires: Pro-resolving mediators, air pollution, and smoking
Thatcher, T. H., Woeller, C. F., McCarthy, C. E., & Sime, P. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.001 · Cited by 30
“Another recent study also showed macrophages can also produce maresins such as 13S,14S-epoxy-maresin (13,14-eMar) and MaR1, derived from DHA (Dalli et al., 2013).”
Zheng, S., Ma, M., Li, Z.-W., Yu, H., Li, H., Fu, P., & Jin, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000665rr · Cited by 29
Balta, M. G., Papathanasiou, E., & CHRISTOPOULOS, P. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632238 · Cited by 30
“In vitro treatment with the bioactive SPM, 13,14-epoxy-MaR resulted in higher levels of MaR1 in M2 macrophages (CD163 and CD206) compared to M1 macrophages (CD54 and CD80), suggesting a higher predisposition towards the proresolving activity of this macrophage subtype (84).”
BackgroundResultInfluentialNew Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation
Camba-Gómez, M., Gualillo, O., & Conde, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052605 · Cited by 31
Artru, F., McPhail, M. J. W., Triantafyllou, E., & Trovato, F. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867261 · Cited by 32
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 34
“MaR1 directly enhances neutrophil activation and plays an important role in switching macrophages from the M1 to the M2 phenotype [248,249,262].”
BackgroundZhao, M., Zheng, Z., Yin, Z., Zhang, J., Qin, J., Wan, J., & Wang, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106832 · Cited by 27
Actions of SPM in regulating host responses in arthritis
Perretti, M., & Norling, L. V. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.005 · Cited by 29
The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
Maciejewska, D., Stachowska, E., Hawryłkowicz, V., Stachowska, L., & Prowans, P. (2021) · Biomolecules · doi:10.3390/biom11070937 · Cited by 27
“It is considered that 13, 14-epoxide intermediates might have a positive influence on the pathway of maresin biosynthesis and boost anti-inflammatory effect [48].”
BackgroundLiotti, F., Marotta, M., Melillo, R. M., & Prevete, N. (2022) · Cancers · doi:10.3390/cancers14143333 · Cited by 32
Chi, M. N., Luz‐Crawford, P., Balas, L., Sipka, T., Contreras-López, R. A., Barthelaix, A., Lutfalla, G., Durand, T., Jørgensen, C., & Djouad, F. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15156 · Cited by 28
Extracellular vesicles of MSCs and cardiomyoblasts are vehicles for lipid mediators
Pizzinat, N., Ong‐Meang, V., Bourgailh-Tortosa, F., Blanzat, M., Perquis, L., Cussac, D., Parini, A., & Poinsot, V. (2020) · Biochimie · doi:10.1016/j.biochi.2020.07.013 · Cited by 27
Lastrucci, C., Baillif, V., Béhar, A., Saati, T. A., Dubourdeau, M., Maridonneau‐Parini, I., & Cougoule, C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259341 · Cited by 28
“, RvD1 and MaR1) also influence macrophage polarization by either inducing the expression of M2 markers or inhibitingM1 activation state (52, 53).”
BackgroundTungen, J. E., Gerstmann, L., Vik, A., Matteis, R. D., Colas, R. A., Dalli, J., Chiang, N., Serhan, C. N., Kalesse, M., & Hansen, T. V. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201806029 · Cited by 28
Self-citationAlqahtani, S., Xia, L., Jannasch, A., Ferreira, C. R., Franco, J., & Shannahan, J. H. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115730 · Cited by 25
Resolution of chronic inflammation and cancer
Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 34
Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease
Spite, M. R. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003030 · Cited by 25
Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases
Zhao, M., Li, C., Zhang, J., Yin, Z., Zheng, Z., Wan, J., & Wang, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106337 · Cited by 28
First total synthesis of pro-resolving and tissue-regenerative Maresin sulfido-conjugates
Rodríguez, A. R., & Spur, B. W. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.04.131 · Cited by 23
Toewe, A., Balas, L., Durand, T., Geißlinger, G., & Ferreirós, N. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.05.020 · Cited by 22
“Several approaches for the determination of pro-resolving lipid mediators in biological samples have been described in the bibliography:maresin 1 (MaR1) and LXA4 in human synovial fluid taken from rheumatoid arthritis patients [11], LXA4, 15-epi-LXA4 (ATL), MaR1, protectin DX (PDX) as well as D-series resolvins and 17…”
BackgroundPrimdahl, K. G., Tungen, J. E., Souza, P. R., Colas, R. A., Dalli, J., Hansen, T. V., & Vik, A. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02113e · Cited by 22
Self-citationResolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases
Hiram, R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07230-6 · Cited by 24
Munir, F., Jamshed, M. B., Shahid, N., Muhammad, S. A., Bhandari, A., & Zhang, Q. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00078.2019 · Cited by 21
Halade, G. V., & Tourki, B. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_6 · Cited by 22
Homann, J., Lehmann, C., Kahnt, A. S., Steinhilber, D., Parnham, M. J., Geißlinger, G., & Ferreirós, N. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.07.068 · Cited by 21
Specialized pro-resolving lipid mediators in endodontics: a narrative review
Aubeux, D., Peters, O. A., Hosseinpour, S., Tessier, S., Geoffroy, V., Pérez, F., & Gaudin, A. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01619-8 · Cited by 24
Protective Potential of Maresins in Cardiovascular Diseases
Liu, M., He, H., & Chen, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.923413 · Cited by 23
Synthesis of maresin 1 and (7S)-isomer
Ogawa, N., Tojo, T., & Kobayashi, Y. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.03.065 · Cited by 19
Rodríguez, M. J., Herrera, F., Donoso, W., Castillo, I., Orrego, R., González, D. R., & Zúñiga‐Hernández, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228827 · Cited by 18
Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents
Tungen, J. E., Aursnes, M., Ramon, S., Colas, R. A., Serhan, C. N., Olberg, D. E., Nuruddin, S., Willoch, F., & Hansen, T. V. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob01232f · Cited by 20
Self-citationImmunoresolvents in asthma and allergic diseases: Review and update
Lotfi, R., Rezaiemanesh, A., Mortazavi, S. H., Karaji, A. G., & Salari, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27836 · Cited by 18
The impact of thrombo‐inflammation on the cerebral microcirculation
Ansari, J., & Gavins, F. N. E. (2021) · Microcirculation · doi:10.1111/micc.12689 · Cited by 20
Kolawole, O. R., & Kashfi, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177924 · Cited by 20
12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation
Sezin, T., Ferreirós, N., Jennrich, M., Ochirbold, K., Seutter, M., Attah, C., Mousavi, S., Zillikens, D., Geißlinger, G., & Sadik, C. D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102528 · Cited by 18
Polyunsaturated Fatty Acids and Their Immunomodulatory Actions in Periodontal Disease
Panezai, J., & Dyke, T. E. V. (2023) · Nutrients · doi:10.3390/nu15040821 · Cited by 22
“13(S),14(S)-epoxymaresin also inhibits the production of LTB4 derived from AA through direct inactivation of the LTA4 hydrolase enzyme, which catalyzes the conversion of leukotriene A4 into the pro-inflammatory metabolite, LTB4 [67].”
BackgroundInfluentialZahoor, I., Nematullah, M., Ahmed, M. E., Fatma, M., Sajad, M., Ayasolla, K., Cerghet, M., Palaniyandi, S. S., Ceci, V., Carrera, G., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108226 · Cited by 21
“They are highly conserved resolution mediators with potent anti-in fl ammatory and pro-resolving properties that contribute to tissue regeneration in acute or chronic in fl ammatory – related disease models (18 – 20).”
Manickam, M., Meenakshisundaram, S., & Pillaiyar, T. (2021) · Archiv der Pharmazie · doi:10.1002/ardp.202100367 · Cited by 17
Fukuishi, N., Takahama, K., Kurosaki, H., Ono, S., & Asai, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041491 · Cited by 18
“The 12-LOX expression has been reported to positively correlate with the differentiation of monocytes into macrophages and dendritic cells [121], and this correlation supports the hypothesis that MaRs are endogenous regulators of monocyte differentiation.”
Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis
Sun, Y., Sun, S., Chen, P., Dai, Y., Yang, D. J., Lin, Y., & Yi, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107113 · Cited by 15
The regulatory effect of specialized pro-resolving mediators on immune cells
Pan, G., Zhang, P., Yang, J., & Wu, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113980 · Cited by 16
The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide
Garić, D., Dumut, D. C., Shah, J., Sanctis, J. B. D., & Radzioch, D. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03530-x · Cited by 17
Siglec-F + neutrophils promote the resolution of acute lung injury through ALOX15 induction
Tavares, L. P., Brüggemann, T. R., Cagnina, R. E., Nshimiyimana, R., Villaseñor-Altamirano, A. B., Rezende, R. M., Lanser, T. B., Liu, X., Bateman, M. E., Krishnamoorthy, N., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.aeb2657 · Cited by 16
Self-citationDubé, L., Spahis, S., Lachaîne, K., Lemieux, A., Monhem, H., Poulin, S.-M., Randoll, C., Travaillaud, E., Ould-Chikh, N.-E.-H., Marcil, V., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0156 · Cited by 15
Mane, S., Kumari, P., Singh, A., Taneja, N. K., & Chopra, R. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2124505 · Cited by 18
“…DHA forms (RvDs) D-series Resolvins, Maresins (MaRs) oxygenated by enzymes, and neuroprotectins/Protectins (NPDs/PDs) (Ward 2015; Isobe et al. 2013; Dalli et al. 2013; Serhan et al. 2006; Arita et al. 2005; Mukherjee et al. 2004; Marcheselli et al. 2003; Serhan et al. 2002; Serhan et al. 2000).”
BackgroundBrücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018008 · Cited by 16
Stereoselective synthesis of MaR2n-3 DPA
Sønderskov, J., Tungen, J. E., Palmas, F., Dalli, J., Serhan, C. N., Stenstrøm, Y., & Hansen, T. V. (2019) · Tetrahedron Letters · doi:10.1016/j.tetlet.2019.151510 · Cited by 14
Self-citationWeylandt, K. H., Karber, M., Xiao, Y., Zhang, I. W., Pevny, S., Blüthner, E., von Schacky, C., Rothe, M., Schunck, W., & Pape, U. F. (2022) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2448 · Cited by 14
“27 The level of 12 ‐ HETE remained unaffected during the whole study period, whereas the levels of 12 ‐ HEPE and 14 ‐ HDHA were lower during the washout period.”
BackgroundSpecialized pro-resolving lipid mediators and resolution of viral diseases
Ferri, G., Mucci, M., Mattoscio, D., & Recchiuti, A. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106762 · Cited by 13
Gambari, L., Cellamare, A., Grassi, F., Grigolo, B., Panciera, A., Ruffilli, A., Faldini, C., & Desando, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119340 · Cited by 14
Fabrication and Characterization of Calcium-Phosphate Lipid System for Potential Dental Application
Zhu, N., Wang, D., Xie, F., Qin, M., Lin, Z., & Wang, Y. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00161 · Cited by 12
“Specific primers (listed as Table 1) for Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), dentin sialophosphoprotein (DSPP), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-2), alkaline phosphatase (ALP), osteocalcin (OCN), runt-related transc…”
BackgroundInfluentialQiu, T., Li, X., Chen, W., He, J., Shi, L., Zhou, C., Zheng, A., Lei, Z., Tang, C., Yu, Q., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1132791 · Cited by 15
“Maresin-1 is one of the metabolites derived from docosahexaenoic acid (DHA), which has been shown to have various intensively anti-inflammatory effects in inflammatory diseases (27).”
BackgroundThe Roles of sPLA2s in Skin Homeostasis and Disease
Yamamoto, K., Hakoi, H., Nomura, S., & Murakami, M. (2023) · Biomolecules · doi:10.3390/biom13040668 · Cited by 11
“Moreover, these ω3 PUFA-derived lipid mediators can facilitate the polarization of anti-inflammatory M2 macrophages [76,77], consistent with the fact that fewer M2 macrophages are present in the LNs of Pla2g2d−/− mice [70].”
Result
Metadata
- Authors
- Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Southern California (US)
- Karolinska Institutet (SE)
- Corresponding author
- Petasis, Nicos A.
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-03-15
- Volume
- 27
- Issue
- 7
- Pages
- 2573-2583
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3688739
- OpenAlex
- W2100994932
- Cited by
- 283
- References
- 32
- Citations by year
- 2026: 20 · 2025: 14 · 2024: 13 · 2023: 25 · 2022: 23 · 2021: 23 · 2020: 30 · 2019: 19 · 2018: 28 · 2017: 26 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 4
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P01GM095467)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- maresin 1, epoxyeicosatrienoic acids, docosahexaenoic acid, 12-lipoxygenase, leukotriene A4 hydrolase, macrophage phenotype, leukotriene B4, specialized pro-resolving mediators, eicosanoid biosynthesis
- MeSH terms
- Arachidonate 12-Lipoxygenase, Cells, Cultured, Docosahexaenoic Acids, Epoxide Hydrolases, Humans, Leukotriene B4, Macrophages, Models, Chemical, Magnetic Resonance Spectroscopy, Molecular Structure, Arachidonic Acid, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.